Page 268 - Read Online
P. 268

Cho et al. Hepatoma Res 2016;2:259-63                                Hepatoma Research
           DOI: 10.20517/2394-5079.2016.13
                                                                                                  www.hrjournal.net
            Topic: Advances in Minimally Invasive Cirrhotic Surgery                             Open Access


           Laparoscopic liver resection for

           hepatocellular carcinoma in patients with

           cirrhosis



           Jai Young Cho, Ho-Seong Han

           Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul 463-707, South Korea.
           Correspondence to: Dr. Ho-Seong Han, Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of
           Medicine, 300 Gumi-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 463-707, South Korea. E-mail: hanhs@snubh.org
           How to cite this article: Cho JY, Han HS. Laparoscopic liver resection for hepatocellular carcinoma in patients with cirrhosis. Hepatoma Res
           2016;2:259-63.

                            Dr. Ho-Seong Han is a Professor of Department of Surgery, Seoul National University Bundang Hospital, Seoul
                            National University College of Medicine. He graduated from Seoul National University College of Medicine in
                            1984, and finished internship and residency of Department of Surgery at Seoul National University Hospital
                            in 1989. His field of interest is hepatobiliary surgery and laparoscopic surgery. He performed laparoscopic
                            right posterior sectionectomy, central bisectionectomy for hepatocellular carcinoma as world-first. He has also
                            performed laparoscopic liver resection in pediatric patient and succeeded in total laparoscopic right side donor
                            hepatectomy as world-first. He plays an important role in many societies.

                                         ABSTRACT
            Article history:             Hepatocellular carcinoma (HCC) is a common malignant tumor and many cases occur in
            Received: 11-05-2016         patients with liver cirrhosis. Although liver transplantation is the most effective treatment
            Accepted: 09-08-2016         option, hepatectomy is still the first curative treatment option because liver transplantation
            Published: 30-09-2016        is limited by the donors and high cost. In recent years, laparoscopic liver resection (LLR)
                                         has increasingly been performed in patients with liver cirrhosis, and has several advantages
            Key words:                   over open liver resection. Besides less pain and shorter hospital stay, LLR in patients with
            Laparoscopy,                 liver cirrhosis is also associated with lower incidences of postoperative liver failure and
            hepatectomy,                 ascites because of greater preservation of collateral veins and less liver manipulation. With
            cirrhosis,                   increasing experience, LLR for HCC located in segments 7 or 8 is now feasible, and anatomic
            portal hypertension          LLR could be performed in patients with cirrhosis. Many comparative studies have shown
                                         that LLR is better than open liver resection in patients with liver cirrhosis in terms of a lower
                                         incidence of postoperative liver failure and similar patient survival. In conclusion, LLR is a
                                         promising treatment modality for HCC in patients with liver cirrhosis.

           INTRODUCTION                                       liver cancer,  and the third most common cause of
                                                                         [1]
                                                              cancer-related  death worldwide.  Most HCCs  are
                                                                                            [2]
           Hepatocellular  carcinoma  (HCC)  is  the  fifth  most   found in patients with liver cirrhosis, although HCC
           common malignant tumor, the most common primary    occurs in 60-90% of all patients with liver cirrhosis. [3]
                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

                        © 2016 OAE Publishing Inc.  www.oaepublish.com                                    259
   263   264   265   266   267   268   269   270   271   272   273